Clinical Trials Logo

Clinical Trial Summary

To evaluate the efficacy and the safety of concomitant use of Ezetimibe/Rosuvastatin combination tablets and Candesartan cilexetil/Amlodipine besylate combination tablets compared to each combination tablet alone in patients with essential hypertension (HTN) and hyperlipidemia.


Clinical Trial Description

To improve the ease of use of high blood pressure and hyperlipidemia to improve patient compliance and reduce the risk of cardiovascular disease. And It is recommended to identify the need to develop a combination of Candesartan cilexetil/Amlodipine besylate combination tablets , and Ezetimibe/Rosuvastatin combination tablets. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03847506
Study type Interventional
Source HK inno.N Corporation
Contact
Status Completed
Phase Phase 4
Start date July 5, 2018
Completion date December 2, 2020

See also
  Status Clinical Trial Phase
Completed NCT01918709 - Drug Interaction and Safety Between Valsartan and Rosuvastatin in Healthy Male Volunteers Phase 1
Completed NCT02994745 - A Clinical Trial to Evaluate the Pharmacokinetics and Safety/Tolerability of Fimasartan and Atorvastatin in Healthy Male Volunteers. Phase 1
Completed NCT02995720 - A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin Phase 1